查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
神經生物標記市場與 COVID-19 影響分析，按類型、按應用、按最終用途、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1335304

神經生物標記市場與 COVID-19 影響分析，按類型、按應用、按最終用途、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Neurological Biomarkers Market with COVID-19 Impact Analysis, By Type, By Application, By End-use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 318 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年神經生物標記市場規模為 56.079 億美元，2023 年至 2030 年年複合成長率為 15.8%。

神經生物標記市場-市場動態：

  • 技術進步不斷進步，精準醫學不斷發展。
  • 生物標記（包括生物標記特徵）的不斷進步使得神經系統疾病更容易治療。因此，可以實現更快的藥物開發、早期診斷和無創測試。此外，數位生物標記為各製藥公司提供了補充資訊，以得出臨床試驗的決策。反過來，這些因素又推動了神經生物標記市場的成長。此外，在個性化醫療中，神經退行性疾病的生物標記研究是一個很大的進步領域。各種分子已與各種神經退行性疾病相關聯並進行了評估。因此，生物製藥行業受到精準醫學發展的影響。從生物製藥到診斷公司，具有多種職能的不同參與者，包括商業營運和研發，將發生巨大的變化。這歸因於對市場成長的積極影響。然而，生物標記開發週期長和啟動成本高預計將抑制市場成長。此外，在多個研究階段提供資金的組織的廣泛存在預計將為市場擴張提供良好的機會。為了支持與阿滋海默症和大腦衰老的健康差異相關的研究，美國國立衛生研究院 (NIH) 正在提供額外的資金，因此這一因素可能會推動市場的成長。

神經生物標記市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，預計全球神經生物標記市場在預測期內（2023-2030 年）每年將以 15.8% 左右的年複合成長率成長
  • 由於生物標記的不斷進步，神經生物標記行業預計將以顯著的速度成長
  • 根據類型細分，預計基因組將在 2022 年顯示出最大的市場佔有率
  • 根據應用細分，阿滋海默症是2022年的主導類型
  • 按地區分類，北美是 2022 年的主要收入來源

神經生物標記市場-細分分析：

  • 全球神經生物標記市場根據類型、應用、最終用途和區域進行細分。
  • 市場根據類型分為四類：成像、蛋白質組、基因組、代謝組等。在預測期內，基因組部分可能會保持其主導地位。該細分市場為根據個人對疾病的易感性和特定遺傳變異開發個性化藥物和診斷提供了各種機會。此外，用於鑑定基因組生物標記的存在或研究基因組生物標記以檢測與疾病相關的DNA 序列變異的方法包括使用單核苷酸多態性(SNP) 的全基因組關聯研究、陣列比較基因組雜交(CGH)、全基因組重測序和基因表達譜。
  • 根據應用，市場分為四類：多發性硬化症、阿滋海默症、自閉症譜系障礙、帕金森氏症等。阿滋海默症領域預計將主導市場。這一成長歸因於疾病負擔的增加和臨床使用產品的可用性，包括用於診斷的成像生物標記——澱粉樣蛋白 PET 示踪劑。此外，非營利組織和政府組織正在提供大量可能促進市場成長的研究機會。
  • 根據最終用途，市場分為三類：研究組織、醫院和醫院實驗室、獨立臨床診斷中心等。由於住院人數的增加，醫院和醫院實驗室部門可能會在預測期內保持其主導地位。此外，醫療基礎設施的不斷發展也增強了醫院設施。許多基於血液的生物標記檢測方法均由醫院擁有並大量使用。此外，由於擴大採用生物標記、門診手術中心（ASC）和製藥公司進行藥物發現和開發，研究機構的成長速度最快

神經生物標記市場-地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

神經生物標記市場-競爭格局：

失智症、腦腫瘤、偏頭痛、癲癇和阿滋海默症等神經系統疾病患病率的上升歸因於市場的成長。此外，在神經系統疾病中，早期診斷的要求和技術進步等因素也促進了市場的成長。此外，市場參與者採取的策略使他們能夠利用導致創新產品的開發並增強其供應鏈。在此基礎上，戰略包括推出各種產品、合作、協議、收購和技術進步，以在市場上立足。例如，2020 年 8 月，Enigma Biomedical Group 宣布簽署協議，獲得楊森的新型神經成像生物標記許可。此外，這些生物標記物有望為增進我們對一系列神經退行性疾病（包括阿滋海默症和其他失智症）的理解提供重要的新工具。

最近的發展：

例如，2021 年 4 月，Quanterix Corp. 舉辦了一場由頂級行業專業人士參加的網路研討會，討論與 pTau181、pTau217、pTau231 和其他神經生物標記超靈敏測量相關的神經學進展。

該研究的主要特點：

  • 這項關於神經生物標記市場的擬議研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030），以 2022 年為基準年。
  • 該報告為客戶提供了有關神經生物標記市場的最新趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了神經生物標記市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、老牌參與者面臨的挑戰以及神經生物標記市場維持的成長因素。
  • COVID-19 對神經生物標記市場規模、預測、年複合成長率和市場動態的影響將在研究範圍下詳細討論。還將涵蓋對新冠疫情后神經生物標記市場的詳細見解。
  • 為了讓本報告的用戶全面了解神經生物標記市場，我們還包括了神經生物標記市場的競爭格局和關鍵創新者分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這些參與者將幫助用戶了解在神經生物標記市場營運的參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球神經生物標記市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師。

目錄

第 1 章：神經生物標記市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的神經生物標記市場片段
    • 神經生物標記市場片段（按應用）
    • 按最終用途分類的神經生物標記市場片段
    • 按國家/地區分類的神經生物標記市場片段
    • 按地區分類的神經生物標記市場片段
  • 競爭洞察

第 3 章：神經生物標記主要市場趨勢

  • 神經生物標記市場促進因素
    • 市場促進因素的影響分析
  • 神經生物標記市場限制
    • 市場限制影響分析
  • 神經生物標記市場機會
  • 神經生物標記市場未來趨勢

第 4 章：神經生物標記行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：神經生物標記市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：神經生物標記市場格局

  • 2022 年神經生物標記市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：神經生物標記市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 影像學
    • 蛋白質組學
    • 基因組
    • 代謝組學
    • 其他

第 8 章：神經生物標記市場 -按應用

  • 概述
    • 按應用的細分市場佔有率分析
    • 多發性硬化症
    • 阿爾茨海默氏病
    • 自閉症譜系障礙
    • 帕金森氏症
    • 其他

第 9 章：神經生物標記市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 研究機構
    • 醫院和醫院實驗室
    • 獨立臨床診斷中心
    • 其他

第 10 章：神經生物標記市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • 北美神經生物標記主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲神經生物標記主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區神經生物標記主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按類型）
    • 亞太地區市場規模和預測（按應用）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲神經生物標記主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按類型）
    • 拉丁美洲市場規模和預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲神經生物標記主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 神經生物標記行業

  • 競爭儀表板
  • 公司簡介
    • PERKINELMER INC.
    • Abbott Laboratories
    • Quanterix
    • Thermo Fisher Scientific, Inc.
    • Neurobio
    • Banyan Biomarkers, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. HOFFMANN-LA ROCHE LTD.
    • Merck & Co., Inc.
    • DiaGenic ASA
    • Johnson & Johnson Services, Inc.
    • Myriad Genetics, Inc.

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1582

REPORT HIGHLIGHT

Neurological biomarkers market size was valued at USD 5,607.9 Million in 2022, expanding at a CAGR of 15.8% from 2023 to 2030.

Neurological biomarkers are the biomarkers used for calculating and evaluating a symptom or method for obtaining a pharmacological response to a particular treatment. Additionally, they are extensively used for the identification of various diseases, such as autism, Parkinson's disease, and depression. Moreover, the general types of neurological biomarkers are metabolomics imaging, genomics, and proteomics.

Neurological Biomarkers Market- Market Dynamics:

  • Increasing Technological Advancements and Increasing Development of Precision Medicine.
  • Increasing advancements in biomarkers, including biomarker signatures, make neurological diseases more treatable. As a result, in faster drug development, early diagnosis, and noninvasive testing. In addition, digital biomarkers provide various pharmaceutical companies as well as supplemental information to conclude the decisions for clinical trials. This, in turn, such factors fuel the market growth of neurological biomarkers. Moreover, in personalized medicine, biomarker research in neurodegenerative disease is a large advancing area. Various molecules have been associated and assessed with varied neurodegenerative disorders. Thus, the biopharmaceutical industry is impacted by the evolution of precision medicine. From biopharma to diagnostics companies' different players with several functions, including commercial operations to research and development will observe a huge change. This is attributed to positively impacting the market growth. However, protracted biomarker development cycles and high startup costs are expected to restrain market growth. Furthermore, the wide presence of organizations offering funds at numerous stages of research is expected to provide a great opportunity for market expansion. To support research associated with health disparities in Alzheimer's and brain aging, the National Institutes of Health (NIH) is providing additional funds, therefore this factor may fuel the market growth.

Neurological Biomarkers Market- Key Insights:

  • As per the analysis shared by our research analyst, the global neurological biomarkers market is estimated to grow annually at a CAGR of around 15.8% over the forecast period (2023-2030)
  • The neurological biomarkers industry is projected to grow at a significant rate due to the increasing advancements in biomarkers
  • Based on type segmentation, genomic was predicted to show maximum market share in the year 2022
  • Based on application segmentation, Alzheimer's disease was the leading type in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Neurological Biomarkers Market- Segmentation Analysis:

  • The global neurological biomarkers market is segmented on the basis of type, application, end-use, and region.
  • The market is divided into four categories based on type: imaging, proteomic, genomic, metabolomic, and others. The genomic segment is likely to maintain its dominance during the forecast period. The segment provides various opportunities for the development of personalized medicines and diagnostics based on an individual's predisposition to the disease & specific genetic variations. Additionally, methods used for the identification of the presence or studying genomic biomarkers for detecting disease-associated DNA sequence variants include whole-genome association studies using Single Nucleotide Polymorphisms (SNPs), array Comparative Genomic Hybridization (CGH), whole-genome resequencing, and gene expression profiling.
  • The market is divided into four categories based on application: multiple sclerosis, Alzheimer's disease, autism spectrum disorder, Parkinson's disease, and others. The Alzheimer's disease segment is expected to dominate the market. The growth is attributed to the increasing disease burden and product availability for clinical use, including imaging biomarkers-amyloid PET tracers for diagnosis. Moreover, non-profit and government organizations are offering a plethora of research opportunities that may boost market growth.
  • The market is divided into three categories based on end-use: research organizations, hospital & hospital laboratories, independent clinical diagnostic centers, and others. The hospital & hospital laboratories segment is likely to maintain its dominance over the forecast period due to a rise in hospitalization. Additionally, hospital facilities are enhanced by the ongoing development of healthcare infrastructure. Many blood-based biomarker assays are owned by hospitals and utilized in significant volumes. Moreover, research organizations are accounted to the grow at the fastest owing to the rising adoption of biomarkers ambulatory Surgery Centers (ASCs) and pharmaceutical companies for drug discovery & development

Neurological Biomarkers Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Neurological Biomarkers Market- Competitive Landscape:

The rise in the prevalence of neurological diseases like dementia, brain tumors, migraines, epilepsy, and Alzheimer's disease is attributed to the growth of the market. Additionally, in neurological disorders, the factors such as the requirement for early diagnosis and technological advancements are contributing to market growth. Moreover, strategies adopted by market players that allow them to utilize led to the development of innovative products and enhance their supply chain. Based on this, the strategies include the launch of various products, collaboration, agreement, acquisition, and technological advancements to gain a foothold in the market. For instance, in August 2020, Enigma Biomedical Group announced signing an agreement to License Novel Neuro Imaging Biomarkers from Janssen. Additionally, these biomarkers hold great promise to offer essential new tools in the advancement of our understanding of a range of neurodegenerative diseases, including Alzheimer 's disease and other dementias.

Recent Developments:

For instance, in April 2021, Quanterix Corp. introduced a webinar with top industry professionals to discuss neurological advancements related to the ultra-sensitive measurement of pTau181, pTau217, pTau231, and other neurological biomarkers.

Key features of the study:

  • This proposed research study on neurological biomarkers market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the neurological biomarkers market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for neurological biomarkers market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the neurological biomarkers market.
  • Impact of COVID-19 on neurological biomarkers market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on neurological biomarkers market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the neurological biomarkers market, we have also included competitive landscape and key innovator analysis for the neurological biomarkers market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the neurological biomarkers market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global neurological biomarkers market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROLOGICAL BIOMARKERS MARKET KEY PLAYERS

  • PERKINELMER INC.
  • Abbott Laboratories
  • Quanterix
  • Thermo Fisher Scientific, Inc.
  • Neurobio
  • Banyan Biomarkers, Inc.
  • Bio-Rad Laboratories, Inc.
  • F. HOFFMANN-LA ROCHE LTD.
  • Merck & Co., Inc.
  • DiaGenic ASA
  • Johnson & Johnson Services, Inc.
  • Myriad Genetics, Inc.

GLOBALNEUROLOGICAL BIOMARKERS MARKET, BY TYPE

  • Imaging
  • Proteomic
  • Genomic
  • Metabolomic
  • Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY APPLICATION

  • Multiple Sclerosis
  • Alzheimer's Disease
  • Autism Spectrum Disorder
  • Parkinson's Disease
  • Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY END-USE

  • Research Organizations
  • Hospital & Hospital Laboratories
  • Independent Clinical Diagnostic Centers
  • Others

GLOBAL NEUROLOGICAL BIOMARKERS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neurological Biomarkers Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neurological Biomarkers Market Snippet by Type
    • 2.1.2. Neurological Biomarkers Market Snippet by Application
    • 2.1.3. Neurological Biomarkers Market Snippet by End-use
    • 2.1.4. Neurological Biomarkers Market Snippet by Country
    • 2.1.5. Neurological Biomarkers Market Snippet by Region
  • 2.2. Competitive Insights

3. Neurological Biomarkers Key Market Trends

  • 3.1. Neurological Biomarkers Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neurological Biomarkers Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neurological Biomarkers Market Opportunities
  • 3.4. Neurological Biomarkers Market Future Trends

4. Neurological Biomarkers Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neurological Biomarkers Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Neurological Biomarkers Market Landscape

  • 6.1. Neurological Biomarkers Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neurological Biomarkers Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022&2030 (%)
    • 7.1.2. Imaging
    • 7.1.3. Proteomic
    • 7.1.4. Genomic
    • 7.1.5. Metabolomic
    • 7.1.6. Others

8. Neurological Biomarkers Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Multiple Sclerosis
    • 8.1.3. Alzheimer's Disease
    • 8.1.4. Autism Spectrum Disorder
    • 8.1.5. Parkinson's Disease
    • 8.1.6. Others

9. Neurological Biomarkers Market - By End-use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-use, 2022&2030 (%)
    • 9.1.2. Research Organizations
    • 9.1.3. Hospital & Hospital Laboratories
    • 9.1.4. Independent Clinical Diagnostic Centers
    • 9.1.5. Others

10. Neurological Biomarkers Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Neurological Biomarkers Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Neurological Biomarkers Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Neurological Biomarkers Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Neurological Biomarkers Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Neurological Biomarkers Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-use, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Neurological Biomarkers Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. PERKINELMER INC.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Quanterix
    • 11.2.4. Thermo Fisher Scientific, Inc.
    • 11.2.5. Neurobio
    • 11.2.6. Banyan Biomarkers, Inc.
    • 11.2.7. Bio-Rad Laboratories, Inc.
    • 11.2.8. F. HOFFMANN-LA ROCHE LTD.
    • 11.2.9. Merck & Co., Inc.
    • 11.2.10. DiaGenic ASA
    • 11.2.11. Johnson & Johnson Services, Inc.
    • 11.2.12. Myriad Genetics, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Neurological Biomarkers Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Neurological Biomarkers Market, by Type2018-2030 (USD Million)
  • TABLE Neurological Biomarkers Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Neurological Biomarkers Market, by Application2018-2030 (USD Million)
  • TABLE Neurological Biomarkers Market: End-use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-use
  • TABLE Global Neurological Biomarkers Market, by End-use 2018-2030 (USD Million)
  • TABLE Neurological Biomarkers Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Neurological Biomarkers Market, by Region 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Europe Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE EuropeNeurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Neurological Biomarkers Market, by End-use, 2018-2030 (USD Million)

List of Figures

  • FIGURE Neurological Biomarkers Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022&2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-use segment market share analysis, 2022&2030
  • FIGURE End-use segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Europe Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Asia Pacific Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Latin America Neurological Biomarkers Market share and leading players, 2022
  • FIGURE Middle East and Africa Neurological Biomarkers Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE Germany Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE India Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE Brazil Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Neurological Biomarkers Market share analysis by country, 2022
  • FIGURE Saudi Arabia Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Neurological Biomarkers Market size, forecast and trend analysis, 2018 to 2030 (USD Million)